[(7S,9E,11S,12S,13S,14S,15R,16R,17S,18S,19E,21Z)-26-[(cyclohexylhydrazinylidene)methyl]-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate

C44H59N3O12 — CID 137212558

IUPAC[(7S,9E,11S,12S,13S,14S,15R,16R,17S,18S,19E,21Z)-26-[(cyclohexylhydrazinylidene)methyl]-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate
SMILESCO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(C=NNC5CCCCC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@H](C)[C@H](OC(C)=O)[C@H]1C
InChIInChI=1S/C44H59N3O12/c1-21-14-13-15-22(2)43(55)46-34-29(20-45-47-28-16-11-10-12-17-28)38(52)31-32(39(34)53)37(51)26(6)41-33(31)42(54)44(8,59-41)57-19-18-30(56-9)23(3)40(58-27(7)48)25(5)36(50)24(4)35(21)49/h13-15,18-21,23-25,28,30,35-36,40,47,49-53H,10-12,16-17H2,1-9H3,(H,46,55)/b14-13+,19-18+,22-15-,45-20?/t21-,23-,24+,25-,30-,35-,36+,40+,44-/m0/s1
InChIKeyYKMFNBMXRNKVRU-GAQVUNBUSA-N
MW821.96 g/mol
LogP6.01
Rot. Bonds5

About [(7S,9E,11S,12S,13S,14S,15R,16R,17S,18S,19E,21Z)-26-[(cyclohexylhydrazinylidene)methyl]-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate

[(7S,9E,11S,12S,13S,14S,15R,16R,17S,18S,19E,21Z)-26-[(cyclohexylhydrazinylidene)methyl]-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate (PubChem CID 137212558) has the molecular formula C44H59N3O12 and a molecular weight of 821.96 g/mol. Its IUPAC name is [(7S,9E,11S,12S,13S,14S,15R,16R,17S,18S,19E,21Z)-26-[(cyclohexylhydrazinylidene)methyl]-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate.

Molecular Properties

Compound Name[(7S,9E,11S,12S,13S,14S,15R,16R,17S,18S,19E,21Z)-26-[(cyclohexylhydrazinylidene)methyl]-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate
PubChem CID137212558
Molecular FormulaC44H59N3O12
Molecular Weight821.96 g/mol
Exact Mass821.41
IUPAC Name[(7S,9E,11S,12S,13S,14S,15R,16R,17S,18S,19E,21Z)-26-[(cyclohexylhydrazinylidene)methyl]-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate
SMILESCO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(C=NNC5CCCCC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@H](C)[C@H](OC(C)=O)[C@H]1C
InChIInChI=1S/C44H59N3O12/c1-21-14-13-15-22(2)43(55)46-34-29(20-45-47-28-16-11-10-12-17-28)38(52)31-32(39(34)53)37(51)26(6)41-33(31)42(54)44(8,59-41)57-19-18-30(56-9)23(3)40(58-27(7)48)25(5)36(50)24(4)35(21)49/h13-15,18-21,23-25,28,30,35-36,40,47,49-53H,10-12,16-17H2,1-9H3,(H,46,55)/b14-13+,19-18+,22-15-,45-20?/t21-,23-,24+,25-,30-,35-,36+,40+,44-/m0/s1
InChIKeyYKMFNBMXRNKVRU-GAQVUNBUSA-N
XLogP6.01
TPSA225.70 Ų
H-Bond Donors7
H-Bond Acceptors14
Rotatable Bonds5
Heavy Atoms59
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 500821.96
LogP ≤ 56.01
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hzone_phenol_A(479)', 'substructure': 'N/A'}, {'alert_name': 'keto_naphthol_A(2)', 'substructure': 'N/A'}, {'alert_name': 'catechol', 'substructure': 'N/A'}, {'alert_name': 'hydroquinone', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}

Analyze [(7S,9E,11S,12S,13S,14S,15R,16R,17S,18S,19E,21Z)-26-[(cyclohexylhydrazinylidene)methyl]-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(7S,9E,11S,12S,13S,14S,15R,16R,17S,18S,19E,21Z)-26-[(cyclohexylhydrazinylidene)methyl]-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate?
The IUPAC name of [(7S,9E,11S,12S,13S,14S,15R,16R,17S,18S,19E,21Z)-26-[(cyclohexylhydrazinylidene)methyl]-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate (CID 137212558) is [(7S,9E,11S,12S,13S,14S,15R,16R,17S,18S,19E,21Z)-26-[(cyclohexylhydrazinylidene)methyl]-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate.
What is the SMILES notation for [(7S,9E,11S,12S,13S,14S,15R,16R,17S,18S,19E,21Z)-26-[(cyclohexylhydrazinylidene)methyl]-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate?
The canonical SMILES for [(7S,9E,11S,12S,13S,14S,15R,16R,17S,18S,19E,21Z)-26-[(cyclohexylhydrazinylidene)methyl]-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate is CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(C=NNC5CCCCC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@H](C)[C@H](OC(C)=O)[C@H]1C.
What is the InChIKey of [(7S,9E,11S,12S,13S,14S,15R,16R,17S,18S,19E,21Z)-26-[(cyclohexylhydrazinylidene)methyl]-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate?
The InChIKey is YKMFNBMXRNKVRU-GAQVUNBUSA-N. The full InChI is InChI=1S/C44H59N3O12/c1-21-14-13-15-22(2)43(55)46-34-29(20-45-47-28-16-11-10-12-17-28)38(52)31-32(39(34)53)37(51)26(6)41-33(31)42(54)44(8,59-41)57-19-18-30(56-9)23(3)40(58-27(7)48)25(5)36(50)24(4)35(21)49/h13-15,18-21,23-25,28,30,35-36,40,47,49-53H,10-12,16-17H2,1-9H3,(H,46,55)/b14-13+,19-18+,22-15-,45-20?/t21-,23-,24+,25-,30-,35-,36+,40+,44-/m0/s1.
What are the key properties of [(7S,9E,11S,12S,13S,14S,15R,16R,17S,18S,19E,21Z)-26-[(cyclohexylhydrazinylidene)methyl]-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate?
[(7S,9E,11S,12S,13S,14S,15R,16R,17S,18S,19E,21Z)-26-[(cyclohexylhydrazinylidene)methyl]-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate has a molecular weight of 821.96 g/mol, XLogP of 6.01, 5 rotatable bonds, 7 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for [(7S,9E,11S,12S,13S,14S,15R,16R,17S,18S,19E,21Z)-26-[(cyclohexylhydrazinylidene)methyl]-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate is sourced from PubChem (CID 137212558), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).